GE HealthCare Technologies Inc. $GEHC Shares Bought by Glenmede Trust Co. NA

Glenmede Trust Co. NA grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 279.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 97,830 shares of the company’s stock after purchasing an additional 72,045 shares during the period. Glenmede Trust Co. NA’s holdings in GE HealthCare Technologies were worth $6,964,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in GEHC. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co grew its stake in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the last quarter. Dodge & Cox grew its stake in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after buying an additional 3,693,918 shares during the last quarter. Capital Research Global Investors increased its position in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares in the last quarter. Finally, State Street Corp increased its position in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other GE HealthCare Technologies news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the transaction, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. This represents a 229.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders acquired 12,618 shares of company stock valued at $805,175. 0.36% of the stock is owned by insiders.

GE HealthCare Technologies Stock Up 2.5%

GE HealthCare Technologies stock opened at $69.73 on Tuesday. The business’s 50-day simple moving average is $64.13 and its two-hundred day simple moving average is $70.33. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The company has a market cap of $31.50 billion, a PE ratio of 15.99, a PEG ratio of 1.97 and a beta of 0.72. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the business posted $1.06 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.91 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is 3.21%.

Wall Street Analyst Weigh In

GEHC has been the subject of several recent analyst reports. Evercore reissued an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday. UBS Group upped their price objective on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a report on Friday. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, July 30th. Royal Bank Of Canada began coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price for the company. Finally, HSBC dropped their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.